FORWARD FEATURES CALENDAR

Healthcare & Life Sciences

accuRx raises GBP27.5m in Series B funding round

European healthcare platform accuRx has closed a GBP27.5 million Series B funding round to transform communication across healthcare systems worldwide.  The financing round was led by Lakestar with participation from British Patient Capital, Latitude VS (sister fund to London-based seed investor LocalGlobe), Atomico, Trusted Insight and Encore Capital. The newly

BioInnovation Institute launches Venture Lab programme

BioInnovation Institute (BII), an international commercial foundation with a non-profit objective incubating and accelerating world-class life science research, has announced the first cohort of participants in the Venture Lab acceleration program for early-stage companies.  Comprising a pan-European spread of start-up initiatives and university research projects, the seven ventures are developing

Sentinel makes strategic investment in Midwest Eye Consultants

Sentinel Capital Partners, a private equity firm that invests in promising companies at the lower end of the midmarket, has invested in a new partnership with Midwest Eye Consultants (Midwest Eye), a management service provider to eye care practices in Indiana and northwest Ohio. Midwest Eye is owned and managed

Numan raises USD40m in Series B led by White Star Capital

Numan, a European digital platform for men’s health, has raised USD40 million in a series B funding round to fuel its expansion and meet the growing demand for digital health services.  The round was led by White Star Capital, with participation from existing investors Novator, Vostok New Global, Anthemis Exponential

Shore Capital’s EyeSouth Partners affiliates with Eye Center of St Augustine

EyeSouth Partners has completed an affiliation with Eye Center of St Augustine (ECSA), its sixth in the state of Florida and twenty-fifth affiliation overall.  EyeSouth is an eye care-focused management services organisation backed by Shore Capital Partners, committed to partnering with leading physicians to build a premier network of eye

NorthEdge invests in Meet

Lower mid-market private equity firm NorthEdge has backed the primary management buyout of Meet, an international talent provider to the life sciences sector. Meet is a global talent acquisition partner to some of the world’s most exciting life sciences businesses. The company services clients across three core, high growth verticals:

PetMedix raises USD37m in Series B round

PetMedix has completed an oversubscribed USD37 million (GBP27 million) Series B financing round that will be used to advance its innovative pipeline through clinical development.  The investment brings two new investors into PetMedix: global technology company Tencent and Japanese corporation Kyoritsu Holdings alongside strong continued support from US-based investor Digitalis

Thompson Street Capital Partners acquires Vector Laboratories

Thompson Street Capital Partners (TSCP), a private equity firm based in St Louis, has acquired Vector Laboratories, the Protein Detection business unit of Maravai (NASDAQ: MRVI).  Vector Laboratories is a manufacturer of labelling and visual detection reagents for life science researchers doing tissue-based protein detection and characterisation. The acquisition of

EnteroBiotix raises over USD21m in Series A financing

EnteroBiotix, a biopharmaceutical company developing high-diversity microbial therapeutics that enhance the gut microbiome and target multiple indications, has held the final closing of its oversubscribed USD21.5 million (GBP15.5 million) Series A financing.  The proceeds will be used to further advance the company’s microbiome drug pipeline and underpin its product development

Events

12 November, 2026 – 5:00 pm

Directory Listings